2-69400408-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_001002755.4(NFU1):āc.676A>Gā(p.Asn226Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000836 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001002755.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFU1 | NM_001002755.4 | c.676A>G | p.Asn226Asp | missense_variant | 7/8 | ENST00000410022.7 | NP_001002755.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFU1 | ENST00000410022.7 | c.676A>G | p.Asn226Asp | missense_variant | 7/8 | 1 | NM_001002755.4 | ENSP00000387219 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251470Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135904
GnomAD4 exome AF: 0.0000882 AC: 129AN: 1461856Hom.: 0 Cov.: 31 AF XY: 0.0000853 AC XY: 62AN XY: 727224
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74376
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2013 | A N22D missense change that is likely pathogenic was identified in the NFU1 gene. It has not been published as a pathogenic variant nor has it been reported as a benign polymorphism to our knowledge. The amino acid change is non-conservative as an uncharged Asparagine residue is replaced by a negatively charged Aspartic Acid residue. This change occurs at a highly conserved position in the NFU1 protein, and multiple in-silico analysis programs predict that N22D is damaging to the NFU1 protein. Therefore, N22D is a strong candidate for a pathogenic variant, however the possibility that it is a benign variant cannot be excluded. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 23, 2023 | Variant summary: NFU1 c.676A>G (p.Asn226Asp) results in a conservative amino acid change located in the C-terminal domain (IPR001075) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 251470 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.676A>G in individuals affected with Multiple Mitochondrial Dysfunctions Syndrome 1 has been reported. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant may have an impact on protein-protein interactions as well as a defect in lipoylation, however, these findings did not allow convincing conclusions about the variant effect (e.g., Jain_2020). The following publication was ascertained in the context of this evaluation (PMID: 32776106). One submitter has reported clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Multiple mitochondrial dysfunctions syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 30, 2019 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with NFU1-related disease. ClinVar contains an entry for this variant (Variation ID: 418385). This variant is present in population databases (rs377381866, ExAC 0.001%). This sequence change replaces asparagine with aspartic acid at codon 226 of the NFU1 protein (p.Asn226Asp). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and aspartic acid. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at